InvestHub

Glaukos Corporation (GKOS)

Glaukos Corporation operates as an ophthalmic medical technology and pharmaceutical enterprise, primarily focused on pioneering novel therapies for glaucoma, corneal disorders, and retinal diseases. The company offers a range of micro-bypass stents, including iStent, iStent inject, and iStent inject W.

Descriptive
Exchange
Industry
Country
Active:none
CompanyRating
Loading data…

Saved screens and full data - with a subscription

Subscribe to save filters and unlock all columns and ratings.

Subscribe - €24.90/mo